Immuntherapie der multiplen Sklerose
Author:
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00108-015-3668-1.pdf
Reference38 articles.
1. Arzneimittelkommission der deutschen Ärzteschaft. http://akdae.de/Arzneimittelsicherheit/RHB/Archiv/index.html. Zugegriffen: 4. Januar 2015
2. Chen H, Assmann JC, Krenz A et al (2014) Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate’s protective effect in EAE. J Clin Invest 124:2188–2192
3. Cohen JA, Coles AJ, Arnold DL et al (2012) Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet 380:1819–1828
4. Coles AJ, Fox E, Vladic A et al (2012) Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial. Neurology 78:1069–1078
5. Coles AJ, Twyman CL, Arnold DL et al (2012) Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet 380:1829–1839
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antimicrobial and Immunomodulatory Properties and Applications of Marine-Derived Proteins and Peptides;Marine Drugs;2019-06-12
2. MicroRNAs associated with the pathogenesis of multiple sclerosis;Journal of Neuroimmunology;2016-06
3. Immunomodulatory properties of shellfish derivatives associated with human health;RSC Advances;2016
4. Krankheitsbild Multiple Sklerose;Weißbuch Multiple Sklerose;2016
5. Functional electrical stimulation through direct 4-channel nerve stimulation to improve gait in multiple sclerosis: a feasibility study;Journal of NeuroEngineering and Rehabilitation;2015-11-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3